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Confidentiality is an agreement between a
doctor and a patient that information dis-
cussed during or after a consultation will
not be divulged to other parties without
the patient’s explicit authorisation.1
Without assurances of confidentiality
patients may be unwilling to give doctors
the information they need to provide good
care. This article examines the scope and
limits of confidentiality in the case of ado-
lescent patients.
Suggestions that adolescents should be
allowed to make medical decisions with-
out parental consent or knowledge are
controversial,2 despite evidence that ado-
lescents may avoid seeking medical care if
they think doctors will inform their par-
ents.3 While most young children are
probably not capable of making indepen-
dent medical decisions without their par-
ents’ awareness, this may not be the case
for teenagers whose decisional capacity
and maturity vary widely from early to
late adolescence. Furthermore, the extent
and legitimacy of parental involvement in
adolescents’ medical treatment during the
transitional period between childhood and
adulthood are uncertain. Consequently,
doctors treating adolescents may face a
dilemma when balancing adolescents’
interests in receiving appropriate, confi-
dential care and parents’ wishes to know
about the condition of their minor chil-
dren and to make decisions regarding
their care.1 To illustrate some of the issues
that may arise in clinical practice consider
the scenario shown in the box.
In South Africa, a child is any person
under 18 years of age.4 In this article ado-
lescents are broadly defined as being
between 12 and 17 years of age.
REASONS FOR CONFIDENTIALITY
Confidentiality promotes trust between
patients and doctors. Adolescents will
only share sensitive or potentially damag-
ing information if they trust their doctors
to safeguard it. By allowing patients con-
trol over who has access to personal and
intimate information, confidentiality pro-
motes full and honest disclosure.
Adolescents are particularly reluctant to
seek help for sensitive issues such as con-
traception, pregnancy, sexually transmit-
ted infections and substance abuse unless
their confidentiality is assured.1 If adoles-
cents doubt their doctors’ willingness to
respect confidentiality they may withhold
information, delay seeking care or refuse
care.1 Therefore, a primary reason for
medical confidentiality is to ensure timely,
accurate diagnosis and treatment to pro-
tect adolescents’ health and often the pub-
lic health as well.
Apart from its beneficial consequences,





















Confidentiality and the 
adolescent patient
Doctors may find themselves in an invidious 
position, trying to balance loyalty to family
against confidentiality.
Chantal is a bright 16-year-old who
presents to her general practitioner
(GP) with vague symptoms of nausea
and lethargy. She tells her GP she is in
a sexual relationship with a university
student whom she has been dating for 6
months. She requests a prescription for
oral contraception. She pleads with the
GP not to tell her parents, who feel ‘the
relationship is too serious’. The GP has
known Chantal since she was 3 years
old. Should the GP prescribe contra-
ception without informing her parents?
Should he persuade Chantal to involve
her parents?  What if she refuses?  What
if she is pregnant?
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lescents because of their unique
developmental needs, particularly
their desire for adult status and
psychological separation from their
parents. As adolescents assume
increasing responsibility for their
lives they look less to parents for
approval and validation of their
choices. Indeed, an important part
of growing up is learning to make
decisions on one’s own. Arguably,
the psychological requirements for
becoming an independent, self-suf-
ficient adult provide ‘... a basis for
a distinctively adolescent right to
privacy and confidentiality’, espe-
cially from parents whom, rightly
or wrongly, adolescents perceive as
intruding in their private lives.5
LIMITS OF 
CONFIDENTIALITY
However, adolescents are not yet
adults and their transitional status
affects the scope of confidentiality.
As long as adolescents are part of a
functioning family it can be argued
that they are legitimately subject to
parental guidance and supervision.5
What then is the scope of confi-
dentiality during adolescence?
What considerations might justify a
doctor’s decision to reveal confi-
dential information to a parent?
Adolescents’ maturity, the potential
for harming themselves and others
because of their behaviour, and
parents’ interests in their adoles-
cents’ decisions are pertinent to
disclosure.5
Maturity
With regard to medical decisions,
maturity is usually defined in terms
of competence or capacity to
decide. A person is considered
competent if able to understand a
problem or intervention, to weigh
the risks and benefits of different
options, to weigh the likely short-
and long-term consequences of
each option, and to express a pref-
erence.6 Empirical data show that
from about 14 years of age adoles-
cents possess the necessary intel-
lectual and psychological skills to
make medical decisions to a degree
comparable with adults.7 There is
also explicit legal recognition of
minors’ competence to consent. In
terms of the Child Care Act 74 of
1983, a child over 14 years is legal-
ly competent to consent to any
medical treatment (excluding
surgery) without the assistance of a
parent or guardian.4 Moreover, the
South African Law Commission
has recommended that the age at
which children may consent to
medical treatment be lowered to
12 years.4 Therefore, on empirical
and legal grounds adolescents
should be presumed competent to
make medical decisions on their
own.
Still, even intellectually competent
adolescents may have shortcomings
in their decision-making capacity.
What counts as a risk or benefit in
a medical decision would depend
on the adolescents’ values.
Conceivably, adolescents’ current
preoccupation with, among other
things, physical appearance and
peer acceptance may partially
impair their judgement, leading
them to give inadequate weight to
the effects of decisions on their
future interests. Hence, present
benefits of decisions may receive
disproportionate weight compared
with potential long-term outcomes.
Insofar as adolescents do not have
the perspective needed to evaluate
adequately the lasting significance
of their immediate concerns, they
might be considered immature.
Even so, adults should be slow to
consider such age-appropriate val-
ues and concerns as misguided
merely because they differ from
their own.5
Potential harm to self
Although on balance adolescents
should be presumed capable of
making medical decisions this does
not mean their expressed wishes
may not be overridden if the doc-
tor deems it in their best interests.
The onus rests on the doctor to
establish if a particular adolescent
is mature enough to make a partic-
ular decision.6 Since competence is
decision-relative, adolescents may
be mature enough to make some
decisions but not others; where to
draw the line will depend on the
nature and consequences of the
decision at hand. The more
adverse the expected consequences
of respecting the adolescent’s wish-
es, the more certain the doctor
must be that the adolescent pos-
sesses the necessary maturity.6
Inevitably there will be some deci-
sions few adolescents are mature
enough to make because the risks
(i.e. the likelihood and severity of
potential harm) are too high.5
With this in mind, there will be
some risks against which adoles-
cents need protection.
When an adolescent’s actual or
intended choices are dangerous or
life-threatening, a doctor may justi-
fiably breach confidentiality.
Moreover, the mismatch between
the likelihood and severity of
harmful consequences and the
adolescent’s lack of appreciation of
these risks together with his tenu-
ous grasp of the future, may justify
breaching confidentiality.5 The
decision to disclose confidential
information is justified on grounds








ered to 12 years.
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than the wrong caused by violating
the doctor’s moral duty to main-
tain confidentiality. Circumstances
in which confidentiality may be
broken include suicidal ideation,
serious substance abuse, life-threat-
ening medical conditions (such as
eating disorders) and disclosure of
physical or sexual abuse.1 Should
the clinician encounter a situation
where disclosure is in the adoles-
cent’s interests, there is still a
moral duty to respect the adoles-
cent as a person. To this end, the
doctor needs to inform the adoles-
cent first and, if possible, include
the adolescent in the process of
revealing the confidential informa-
tion.1
Even if agreed that an adolescent’s
well-being is best served by breach-
ing confidentiality, the doctor must
still decide to whom he will dis-
close the private information. In
particular, is the doctor obliged to
tell the adolescent’s parents?
Scope of parental involvement
Parental involvement in adolescent
decision-making can be justified on
grounds of their right to know and
the benefits of their knowing.5 An
important social difference, often
regarded as morally relevant,
between adults and adolescents, is
that adolescents generally live with
their parents and are financially
dependent on them.6 Parents might
argue that since they bear the
financial and other consequences
of their minor child’s medical
choices they should have some
input into those choices. If indeed
parents have a right to know, they
ought to be involved in their ado-
lescents’ medical decisions unless
there are compelling reasons not
to. In other words, there is a moral
presumption in favour of parental
involvement.5 Alternatively, there is
the view that doctors should favour
confidentiality until there are con-
vincing reasons not to; until, that
is, the benefits of involving parents
outweigh the harms of breaching
confidentiality.5 If, for instance, an
adolescent has a serious drug-
abusing habit, successful treatment
may depend on parental collabora-
tion. On balance, where adoles-
cents are sufficiently mature and
legally able to make independent
medical decisions, the presumption
ought to favour confidentiality.
The doctor should elicit the rea-
sons for an adolescent’s insistence
on confidentiality and he/she must
assess the accuracy of these per-
ceptions. Because adolescents fear
parental disapproval, they may
underestimate the support their
parents can provide. Conse-
quently, without evidence to the
contrary, clinicians should at least
encourage adolescents to involve
parents in their medical decisions.5
There will be times when adoles-
cents adamantly refuse to involve
their parents, or any adults, in their
care. There will also be unfortu-
nate situations where parents are
neither interested nor willing to
become involved. If the conse-
quences of no treatment outweigh
the risks of treatment without an
adult family member, the doctor’s
therapeutic duty will require treat-
ment of the otherwise unsupported
adolescent.5
For practical purposes the doctor
should pre-emptively raise issues of
confidentiality with the family dur-
ing early adolescence. The doctor
can explain that in the future the
adolescent will be interviewed
alone for part of each visit. At the
same time, the doctor can reassure
the parents and inform the adoles-
cent that confidentiality will be
broken if the adolescent’s life or
safety is at risk. The adolescent also
needs to know that confidentiality
is reciprocal and parents too may
want to share their concerns with
the doctor.1 If confidentiality issues
are addressed in advance, there
may be less tension should they
manifest during adolescence.
Questions raised in the case
scenario
There are many reasons why
Chantal may not want her parents
to know she is sexually active.
Maybe she is embarrassed or fears
their disapproval — if they find
out, they may insist that she end
the relationship. The GP must
weigh the short- and long-term,
medical and psychosocial conse-
quences of prescribing oral contra-
ception. The GP must decide if
Chantal is competent enough to
make the request on her own.
Chantal is already sexually active,
so even if the GP questions her
maturity, he may decide to pre-
scribe contraception on pragmatic
grounds. If pregnant, Chantal may
want to carry the pregnancy to
term or have an abortion. Either
option carries physical and emo-
tional consequences. If she contin-
ues to insist on confidentiality, the
GP ought to respect her decision
since, at 16, she likely has suffi-
cient maturity and understanding
to judge what is in her best inter-
ests. Still, the GP should encour-
age Chantal to discuss her situa-
tion with her parents or another
adult. He might offer to tell her
parents or be present if she agrees
to tell them personally. Chantal is
legally able to consent to an abor-
tion as well as request contracep-
tion. (The Choice on Termination
The doctor needs to
inform the adoles-
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of Pregnancy Act 92 of 1996
allows pregnant girls of any age to
consent to their own abortion
without the knowledge or involve-
ment of their parents.)  At 16, she
has also reached the legal age of
sexual consent. Therefore her par-
ents’ consent is unnecessary.
Nevertheless as a trusted family
doctor, the GP may face a conflict
of professional loyalties if he feels
he is colluding with Chantal
behind her parents’ backs.
CONCLUSION
Confidentiality in adolescent care
is necessary for developmental rea-
sons and to protect the adoles-
cent’s health. However, confiden-
tiality may be overridden where
there is clear justification such as
risk of serious harm. In general,
adolescents should be encouraged
but not forced to involve their par-
ents in their medical care.





and to protect the
adolescent’s health.
IN A NUTSHELL
Confidentiality bars doctors from dis-
closing information entrusted to
them without patients’ explicit per-
mission.
Adolescents seek confidentiality
because of their unique develop-
mental needs.
Adolescents are unlikely to seek
medical care for sensitive conditions
unless confidentiality is assured.
Adolescents should be encouraged
but not forced to involve their par-
ents in their medical care.
Doctors should pre-emptively inform
adolescents and their parents about
the requirements of confidentiality,
including conditions under which it
may be breached.
Confidentiality may be breached in
exceptional circumstances, such as
risk of serious harm to the adoles-
cent.
Should it become necessary to
breach confidentiality, the doctor
should inform the adolescent first
and try to include him/her in the
process of disclosure.
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SINGLE SUTURE
New markers to determine prognosis in acute coronary 
syndromes 
Elevated levels of the biomarkers C-reactive protein (CRP) and 
B-type natriuretic peptide (BNP) recently have been shown to pre-
dict outcomes in acute coronary syndromes. Now, investigators have
combined testing for these biomarkers with testing for troponin I to
investigate the utility of all 3 biomarkers in combination (Circulation
2002; 105:1760-1763). BNP, CRP, and troponin I were measured
in 450 participants from a multicentre trial of patients with non-
ST-segment-elevation MIs. Each biomarker was an independent
predictor of the primary composite endpoint of death, myocardial
infarction, and heart failure. A simple additive score, devised from
the number of positive biomarkers, was used to categorise patients.
The researchers then tested this scoring system in a larger cohort of
patients who were enrolled in the TACTICS-TIMI 18 study. In 1
635 patients, the number of elevated markers again was a significant
independent predictor of outcome. Six-month relative risk for the
composite endpoint was 3.6 among patients in whom all 3 markers
were elevated, compared with those in whom all biomarkers 
were normal.
This study provides strong evidence that the new biomarkers BNP
and CRP complement standard testing for troponin for predicting
outcomes in patients with acute coronary syndromes. Such additive
benefit may be attributable, in part, to the different nature of each
marker: troponin predominantly indicates myocardial necrosis, CRP
indicates inflammation, and BNP indicates activation of the 
neurohormonal axis.
(Fleischmann K E. Journal Watch May 21, 2002.)
